Počet záznamov: 1
Biosynthesis of galactan in mycobacterium tuberculosis as a viable TB drug target?
Názov Biosynthesis of galactan in mycobacterium tuberculosis as a viable TB drug target? Autor Konyariková Zuzana Kozmon Stanislav 1978- SAVCHEM - Chemický ústav SAV SCOPUS RID ORCID Spoluautori Savková Karin Mikušová Katarína Zdroj.dok. Antibiotics. Vol. 9 (2020), art. no. 20 [25] p. Jazyk dok. eng - angličtina Druh dok. rozpis článkov z periodík (rbx) Ohlasy SHAKU, Moagi - EALAND, Christopher - KANA, Bavesh D. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets. In FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. ISSN 2235-2988, 2020, vol. 10, no., pp. Dostupné na: https://doi.org/10.3389/fcimb.2020.603382. MAALIKI, Carine - FU, Jian - VILLAUME, Sydney - VILJOEN, Albertus - RAYNAUD, Clement - HAMMOUD, Sokaina - THIBONNET, Jerome - KREMER, Laurent - VINCENT, Stephane P. - THIERY, Emilie. Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM. In BIOORGANIC & MEDICINAL CHEMISTRY. ISSN 0968-0896, 2020, vol. 28, no. 13, pp. Dostupné na: https://doi.org/10.1016/j.bmc.2020.115579. VILCHEZE, Catherine. Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs. In APPLIED SCIENCES-BASEL, 2020, vol. 10, no. 7, pp. Dostupné na: https://doi.org/10.3390/app10072278. BATT, Sarah M. - BURKE, Christopher E. - MOOREY, Alice R. - BESRA, Gurdyal S. Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall. In Cell Surface, 2020-12-01, 6, pp. Dostupné na: https://doi.org/10.1016/j.tcsw.2020.100044. CHHABRA, S. - KUMAR, S. - PARKESH, R. Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence. In ACS OMEGA. ISSN 2470-1343, JUN 8 2021, vol. 6, no. 22, p. 14430-14441. Dostupné na: https://doi.org/10.1021/acsomega.1c01314. CHAMPCIAUX, B. - RAYNAUD, C. - VILJOEN, A. - CHENE, L. - THIBONNET, J. - VINCENT, S.P. - KREMER, L. - THIERY, E. Synthesis and biological evaluation of 3,4-dihydro-1H-[1,4] oxazepino [6,5,4-hi] indol-1-ones and 4,6-dihydrooxepino [5,4,3-cd] indol-1(3H)-ones as Mycobacterium tuberculosis inhibitors. In BIOORGANIC & MEDICINAL CHEMISTRY. ISSN 0968-0896, AUG 1 2021, vol. 43. Dostupné na: https://doi.org/10.1016/j.bmc.2021.116248. AHMED, D.M. - CHEN, J.F.M. - SANDERS, D.A.R. Pyrazole and Triazole Derivatives as iMycobacterium tuberculosis/i UDP-Galactopyranose Inhibitors. In PHARMACEUTICALS. FEB 2022, vol. 15, no. 2. Dostupné na: https://doi.org/10.3390/ph15020197. PEPI, M.J. - CHACKO, S. - MARQUS, G.M. - SINGH, V. - WANG, Z. - PLANCK, K. - CULLINANE, R.T. - MEKA, P.N. - GOLLAPALLI, D.R. - IOERGER, T.R. - RHEE, K.Y. - CUNY, G.D. - BOSHOFF, H.I.M. - HEDSTROM, L. A D-Phenylalanine-Benzoxazole Derivative Reveals the Role of the Essential Enzyme Rv3603c in the Pantothenate Biosynthetic Pathway of iMycobacterium tuberculosis/i. In ACS INFECTIOUS DISEASES. ISSN 2373-8227, FEB 11 2022, vol. 8, no. 2, p. 330-342. Dostupné na: https://doi.org/10.1021/acsinfecdis.1c00461. GOLCHHA, N.C. - NIGHOJKAR, A. - NIGHOJKAR, S. Redefining genomic view of Clostridioides difficile through pangenome analysis and identification of drug targets from its core genome. In DRUG TARGET INSIGHTS. ISSN 1177-3928, 2022, vol. 16, p. 17-24. Dostupné na: https://doi.org/10.33393/dti.2022.2469. ALLUE-GUARDIA, A. - GARCIA-VILANOVA, A. - OLMO-FONTANEZ, A.M. - PETERS, J. - MASELLI, D.J. - WANG, Y.F. - TURNER, J. - SCHLESINGER, L.S. - TORRELLES, J.B. Host- and Age-Dependent Transcriptional Changes in iMycobacterium tuberculosis/i Cell Envelope Biosynthesis Genes after Exposure to Human Alveolar Lining Fluid. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, JAN 2022, vol. 23, no. 2. Dostupné na: https://doi.org/10.3390/ijms23020983. Kategória ADMA - Vedecké práce v zahraničných impaktovaných časopisoch registrovaných vo WOS Core Collection alebo SCOPUS Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2020 Registrované v WOS Registrované v SCOPUS DOI 10.3390/antibiotics9010020 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Biosynthesis of galactan in mycobacterium tuberculosis as a viable TB drug target.pdf Prístupný 11.7 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 3.893 Q1 1.173 Q1
Počet záznamov: 1